Contact
Please use this form to send email to PR contact of this press release:
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
TO:
Please use this form to send email to PR contact of this press release:
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
TO: